scispace - formally typeset
K

Karen Broughton

Researcher at Public Health England

Publications -  14
Citations -  1055

Karen Broughton is an academic researcher from Public Health England. The author has contributed to research in topics: Population & Streptococcus pneumoniae. The author has an hindex of 11, co-authored 13 publications receiving 822 citations. Previous affiliations of Karen Broughton include Health Protection Agency.

Papers
More filters
Journal ArticleDOI

Genetic Relationships between Clinical Isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: Characterization of “Atypical” Pneumococci and Organisms Allied to S. mitis Harboring S. pneumoniae Virulence Factor-Encoding Genes

TL;DR: A number of potentially important pathogenic isolates, which were frequently associated with respiratory disease, were identified that phenotypically and genetically are most closely related to S. pneumoniae, S. mitis, and S. oralis.
Journal ArticleDOI

Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data.

Angela B. Brueggemann, +97 more
TL;DR: In this article, the authors investigated the incidence of invasive disease due to these pathogens during the early months of the COVID-19 pandemic and found that containment policies and public information campaigns likely reduced transmission of S pneumoniae, H influenzae, and N meningitidis, leading to a significant reduction in lifethreatening invasive diseases in many countries worldwide.
Journal ArticleDOI

Emerging Trends in the Epidemiology of Invasive Group B Streptococcal Disease in England and Wales, 1991–2010

TL;DR: Although risk of invasive GBS infection remains highest within the first few days of life, the relative burden of disease is shifting toward adults, and the rise in incidence and antibiotic resistance makes development of an effective and safe vaccine all the more pressing.
Journal ArticleDOI

Invasive Pneumococcal Disease in England and Wales: Vaccination Implications

TL;DR: The data indicate that IPD varies by serotype, age, and country, emphasizing that the epidemiology of IPD is heterogeneous and requires continued surveillance.